MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-14-2025
STRATA Skin Sciences Accounts Receivables 2011-2026 | SSKN
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables STRATA Skin Sciences
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.47 M | 3.43 M | 2.94 M | 4.39 M | 3.39 M | 3.14 M | 3.39 M | 4.07 M | 220 K | 57 K | 180 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.47 M | 57 K | 2.7 M |
Quarterly Accounts Receivables STRATA Skin Sciences
| 2025-Q3 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.5 M | 5.25 M | - | 3.98 M | 3.63 M | 4.44 M | 4.8 M | 4.4 M | 3.94 M | 4.47 M | 3.66 M | 2.99 M | 2.97 M | 3.43 M | 3.15 M | 2.85 M | 2.85 M | 2.94 M | 2.94 M | 2.94 M | 2.94 M | 4.39 M | 4.39 M | 4.39 M | 4.39 M | 3.39 M | 3.39 M | 3.39 M | 3.39 M | 3.14 M | 3.14 M | 3.14 M | 3.14 M | 3.39 M | 3.39 M | 3.39 M | 3.39 M | 4.07 M | 4.07 M | 4.07 M | 4.07 M | 220 K | 220 K | 220 K | 221 K | 57 K | 57.2 K | 57.2 K | 57.2 K | 180 K | 180 K | 180 K | 180 K | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.25 M | 57 K | 2.84 M |
Accounts Receivables of other stocks in the Medical devices industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
11.4 M | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
2.37 M | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
97.3 M | $ 13.93 | 5.85 % | $ 2.09 B | USA |
 |
AxoGen
AXGN
|
26.2 M | $ 32.5 | -8.14 % | $ 1.5 B | USA |
 |
Bio-Rad Laboratories
BIO
|
452 M | $ 268.7 | 0.17 % | $ 7.58 B | USA |
 |
Apollo Endosurgery
APEN
|
15 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
1.01 M | - | -20.74 % | $ 369 K | USA |
 |
Aziyo Biologics
AZYO
|
3.26 M | - | 1.37 % | $ 20.5 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
175 M | $ 6.39 | 0.79 % | $ 459 M |  Israel |
 |
BIOLASE
BIOL
|
5.48 M | - | -13.19 % | $ 166 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
44.8 M | - | - | $ 3.31 B | USA |
 |
Apyx Medical Corporation
APYX
|
14 M | $ 3.54 | -0.84 % | $ 123 M | USA |
 |
Conformis
CFMS
|
9.77 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
4.71 M | $ 14.55 | -1.42 % | $ 393 M | USA |
 |
EDAP TMS S.A.
EDAP
|
18.6 M | $ 4.47 | -1.11 % | $ 167 M |  France |
 |
Cardiovascular Systems
CSII
|
39.7 M | - | 0.15 % | $ 844 M | USA |
 |
Bruker Corporation
BRKR
|
566 M | $ 39.77 | 0.53 % | $ 5.93 K | USA |
 |
BioSig Technologies
BSGM
|
109 K | - | 37.08 % | $ 85.7 M | USA |
 |
Dynatronics Corporation
DYNT
|
2.8 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
24.7 M | $ 23.15 | -5.16 % | $ 196 M | USA |
 |
CONMED Corporation
CNMD
|
248 M | $ 46.06 | 1.5 % | $ 1.43 B | USA |
 |
Second Sight Medical Products
EYES
|
455 K | - | -0.97 % | $ 54.4 M | USA |
 |
IRadimed Corporation
IRMD
|
10.6 M | $ 99.09 | -1.92 % | $ 1.26 B | USA |
 |
GBS
GBS
|
595 K | - | -0.57 % | $ 7.12 M | USA |
 |
Cutera
CUTR
|
43.1 M | - | -10.19 % | $ 1.99 M | USA |
 |
Delcath Systems
DCTH
|
10.9 M | $ 9.95 | 2.16 % | $ 284 M | USA |
 |
LivaNova PLC
LIVN
|
193 M | $ 69.05 | 1.02 % | $ 3.75 B |  Britain |
 |
Eargo
EAR
|
1.91 M | - | - | $ 10.2 M | USA |
 |
InMode Ltd.
INMD
|
10.5 M | $ 13.98 | -1.55 % | $ 904 M | Israel |
 |
Pulmonx Corporation
LUNG
|
13.1 M | $ 1.51 | 2.03 % | $ 59.1 M | USA |
 |
Establishment Labs Holdings
ESTA
|
65 M | $ 79.67 | 6.28 % | $ 2.24 B |  Costa-rica |
 |
Myomo
MYO
|
1.9 M | $ 0.65 | -5.24 % | $ 4.58 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
112 K | $ 2.43 | 2.53 % | $ 143 M | Israel |
 |
Invacare Corporation
IVC
|
88 M | - | - | $ 24.7 M | USA |
 |
Orthofix Medical
OFIX
|
136 M | $ 12.75 | -6.18 % | $ 505 M |  Curacao |
 |
Insulet Corporation
PODD
|
161 M | $ 245.25 | -1.66 % | $ 17.3 B | USA |
 |
Globus Medical
GMED
|
679 M | $ 91.88 | -1.63 % | $ 12.4 B | USA |